---
title: "TNDM SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Tandem Diabetes (TNDM), with links to the SEC filings."
url: "https://tradytics.com/research/TNDM/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=TNDM&v=stock-11994860"
---

# TNDM financial statements and SEC filings

## TNDM annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $1.01B | -$187.26M | -$204.71M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/0001438133-26-000010-index.htm) |
| 2024-12-31 | $940.20M | -$99.13M | -$96.03M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/0001438133-26-000010-index.htm) |
| 2023-12-31 | $747.72M | -$233.23M | -$222.61M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/0001438133-26-000010-index.htm) |
| 2022-12-31 | $801.22M | -$92.85M | -$94.59M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813325000036/0001438133-25-000036-index.htm) |
| 2021-12-31 | $702.80M | $22.65M | $15.57M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813324000028/0001438133-24-000028-index.htm) |
| 2020-12-31 | $498.83M | -$7.96M | -$34.38M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813323000031/0001438133-23-000031-index.htm) |

## TNDM annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $881.11M | $725.94M | $155.17M | [10-Q](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000144/0001438133-26-000144-index.htm) |
| 2024-12-31 | $967.66M | $704.56M | $263.10M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/0001438133-26-000010-index.htm) |
| 2023-12-31 | $952.66M | $639.03M | $313.63M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813325000036/0001438133-25-000036-index.htm) |
| 2022-12-31 | $1.05B | $612.84M | $439.95M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813324000028/0001438133-24-000028-index.htm) |
| 2021-12-31 | $905.14M | $472.02M | $433.11M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813323000031/0001438133-23-000031-index.htm) |
| 2020-12-31 | $716.41M | $350.11M | $366.31M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813322000021/0001438133-22-000021-index.htm) |

## TNDM annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$9.72M | -$19.95M | -$43.37M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/0001438133-26-000010-index.htm) |
| 2024-12-31 | $24.23M | -$19.23M | $8.37M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/0001438133-26-000010-index.htm) |
| 2023-12-31 | -$31.81M | -$26.80M | $4.11M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813326000010/0001438133-26-000010-index.htm) |
| 2022-12-31 | $50.46M | -$34.10M | $16.88M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813325000036/0001438133-25-000036-index.htm) |
| 2021-12-31 | $111.36M | -$14.18M | $51.93M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813324000028/0001438133-24-000028-index.htm) |
| 2020-12-31 | $24.67M | -$27.41M | $314.44M | [10-K](https://www.sec.gov/Archives/edgar/data/1438133/000143813323000031/0001438133-23-000031-index.htm) |

- [TNDM stock research](https://tradytics.com/research/TNDM)
- [TNDM financial summary](https://tradytics.com/research/TNDM/financials)
- [Read the data without JavaScript](https://tradytics.com/research/TNDM/fundamentals?snapshot=1)
